Alogliptin-induced bullous pemphigoid

Br J Hosp Med (Lond). 2020 Jul 2;81(7):1-3. doi: 10.12968/hmed.2020.0043. Epub 2020 Jul 29.

Authors

Mansoor Zafar¹, Muhammad Shahbaz², Ian Hawley³, Muhammad Jh Rahmani²

Affiliations

¹ Department of Gastroenterology, Conquest Hospital, East Sussex Healthcare Trust, St Leonards-on-Sea, East Sussex, UK.
² Department of Health and Ageing, Conquest Hospital, East Sussex Healthcare Trust, St Leonards-on-Sea, East Sussex, UK.
³ Department of Histopathology, Conquest Hospital, East Sussex Healthcare Trust, St Leonards-on-Sea, East Sussex, UK.

PMID: 32730152
DOI: 10.12968/hmed.2020.0043

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Diabetes Mellitus, Type 2 / drug therapy
Female
Humans
Hypoglycemic Agents / adverse effects*
Hypoglycemic Agents / therapeutic use
Pemphigoid, Bullous / chemically induced*
Pemphigoid, Bullous / pathology
Piperidines / adverse effects*
Piperidines / therapeutic use
Uracil / adverse effects
Uracil / analogs & derivatives*
Uracil / therapeutic use

Substances

Hypoglycemic Agents
Piperidines
Uracil
alogliptin